Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for ...
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals System ...
Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for Xarelto (rivaroxaban) to include a 10 mg once-daily dose for reducing the risk of venous thromboembolism (VTE) after at least six months of standard anticoagulant therapy. This application is based on data from EINSTEIN CHOICE, which is the only study to find a non-vitamin K antagonist oral anticoagulant (NOAC), specifically two doses of Xarelto (10 mg and 20 mg), to be superior to aspirin in reducing the risk of recurrent VTE, with comparable rates of major bleeding.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Vital Images is highlighting the benefits of its Vitrea solutions as it participates in the 12th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT), July 6-9 in Washington, D.C. The company will focus on the advantages of its Vitrea Advanced Visualization Version 7.
Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF Registry presented at EHRA EUROPACE - CARDIOSTIM 2017. The findings highlight the need for screening to identify atrial fibrillation patients with no symptoms so that stroke prevention treatment can be given.
Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest that measures fluid inside the lungs from outside a person’s clothing. It could be a new way to prevent repeated trips to the hospital for the nearly 6 million Americans living with heart failure.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus catheter, the first and only re-entry ...
Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger agreement for $2.05 billion. The acquisition of Spectranetics will further expand and strengthen Philips’ image-guided therapy business group.
Partho Sengupta, M.D., professor of medicine, director of cardiovascular imaging and chair of cardiac innovations at the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the ...
Mitralign Inc. announced the commencement of its SCOUT II study in Europe, with the Trialign System for the treatment of patients suffering from tricuspid regurgitation.
June 27, 2017 — Senate Majority Leader Mitch McConnell (R-Ky.) and fellow Republicans announced Tuesday that a final ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein ...
June 26, 2017 — Here is a list of some key clinical presentations and video interviews with cardiac ultrasound thought ...
Shockwave Medical recently announced two milestones for its Lithoplasty System for the treatment of calcified plaque in patients with peripheral artery disease (PAD). The first patient was enrolled in the global DISRUPT PAD III clinical trial at the Medical University of Graz, Austria, and the first patient was treated in a commercial case in the United States, at Pottstown Memorial Medical Center in Pottstown, Pa.